| C60 fullerene enhances cisplatin anticancer activity and overcomes tumor cell drug resistance S Prylutska, R Panchuk, G Gołuński, L Skivka, Y Prylutskyy, V Hurmach, ... Nano Research 10, 652-671, 2017 | 82 | 2017 |
| Development of Staphylococcus aureus tolerance to antimicrobial photodynamic inactivation and antimicrobial blue light upon sub-lethal treatment A Rapacka-Zdonczyk, A Wozniak, M Pieranski, A Woziwodzka, ... Scientific Reports 9 (1), 9423, 2019 | 78 | 2019 |
| Characterization of C 60 fullerene complexation with antibiotic doxorubicin YI Prylutskyy, MP Evstigneev, IS Pashkova, D Wyrzykowski, ... Physical Chemistry Chemical Physics 16 (42), 23164-23172, 2014 | 73 | 2014 |
| Structural self-organization of C 60 and cisplatin in physiological solution YI Prylutskyy, VV Cherepanov, MP Evstigneev, OA Kyzyma, VI Petrenko, ... Physical Chemistry Chemical Physics 17 (39), 26084-26092, 2015 | 57 | 2015 |
| Caffeine, pentoxifylline and theophylline form stacking complexes with IQ-type heterocyclic aromatic amines A Woziwodzka, A Gwizdek-Wiśniewska, J Piosik Bioorganic chemistry 39 (1), 10-17, 2011 | 50 | 2011 |
| De-intercalation of ethidium bromide and propidium iodine from DNA in the presence of caffeine J Piosik, K Wasielewski, A Woziwodzka, W Śledź, A Gwizdek-Wiśniewska Open Life Sciences 5 (1), 59-66, 2010 | 47 | 2010 |
| Does C60 fullerene act as a transporter of small aromatic molecules? A Borowik, Y Prylutskyy, Ł Kawelski, O Kyzyma, L Bulavin, O Ivankov, ... Colloids and Surfaces B: Biointerfaces 164, 134-143, 2018 | 44 | 2018 |
| Caffeine and other methylxanthines as interceptors of food-borne aromatic mutagens: inhibition of Trp-P-1 and Trp-P-2 mutagenic activity A Woziwodzka, G Gołuński, D Wyrzykowski, R Kaźmierkiewicz, J Piosik Chemical Research in Toxicology 26 (11), 1660-1673, 2013 | 40 | 2013 |
| Mutagenicity of quaternary ammonium salts containing carbohydrate moieties B Dmochowska, J Piosik, A Woziwodzka, K Sikora, A Wiśniewski, ... Journal of hazardous materials 193, 272-278, 2011 | 32 | 2011 |
| Pentoxifylline as a modulator of anticancer drug doxorubicin. Part II: Reduction of doxorubicin DNA binding and alleviation of its biological effects G Gołuński, A Borowik, N Derewońko, A Kawiak, M Rychłowski, ... Biochimie 123, 95-102, 2016 | 29 | 2016 |
| Potential use of pentoxifylline in cancer therapy G Golunski, A Woziwodzka, J Piosik Current pharmaceutical biotechnology 19 (3), 206-216, 2018 | 27 | 2018 |
| Modulation of acridine mutagen ICR191 intercalation to DNA by methylxanthines—analysis with mathematical models G Gołuński, A Woziwodzka, I Iermak, M Rychłowski, J Piosik Bioorganic & medicinal chemistry 21 (11), 3280-3289, 2013 | 24 | 2013 |
| Polymeric nanocarriers: a transformation in doxorubicin therapies K Butowska, A Woziwodzka, A Borowik, J Piosik Materials 14 (9), 2135, 2021 | 22 | 2021 |
| Genetic variation in IL-10 influences the progression of hepatitis B infection M Rybicka, A Woziwodzka, A Sznarkowska, T Romanowski, P Stalke, ... International journal of infectious diseases 96, 260-265, 2020 | 22 | 2020 |
| Heterocyclic aromatic amines heterocomplexation with biologically active aromatic compounds and its possible role in chemoprevention A Woziwodzka, G Gołuński, J Piosik International Scholarly Research Notices 2013 (1), 740821, 2013 | 20 | 2013 |
| Interactions of newly synthesized platinum nanoparticles with ICR-191 and their potential application A Borowik, R Banasiuk, N Derewonko, M Rychlowski, ... Scientific Reports 9 (1), 4987, 2019 | 17 | 2019 |
| Biophysical characterization of the complexation of C60 fullerene with doxorubicin in a prokaryotic model: Biophysikalische Charakterisierung der Komplexierung von C60‐Fulleren … Y Prylutskyy, A Borowik, G Gołuński, A Woziwodzka, J Piosik, O Kyzyma, ... Materialwissenschaft und Werkstofftechnik 47 (2-3), 92-97, 2016 | 17 | 2016 |
| Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C A Wróblewska, A Bernat, A Woziwodzka, J Markiewicz, T Romanowski, ... Clinical and Experimental Medicine 17, 225-232, 2017 | 12 | 2017 |
| New life of an old drug: Caffeine as a modulator of antibacterial activity of commonly used antibiotics A Woziwodzka, M Krychowiak-Maśnicka, G Gołuński, A Łosiewska, ... Pharmaceuticals 15 (7), 872, 2022 | 11* | 2022 |
| TNF‐α polymorphisms affect persistence and progression of HBV infection A Woziwodzka, M Rybicka, A Sznarkowska, T Romanowski, ... Molecular genetics & genomic medicine 7 (10), e00935, 2019 | 11 | 2019 |
